Overview

DNA Repair Capacity of Afamelanotide on Ultraviolet Radiation-induced DNA Damage in Healthy Volunteers

Status:
Recruiting
Trial end date:
2022-05-27
Target enrollment:
Participant gender:
Summary
This mechanistic study's aim is to assess the DNA damage repair capabilities of afamelanotide in healthy volunteers with skin type I-III following exposure to ultraviolet radiation (UVR)-induced DNA damage.
Phase:
Phase 1
Details
Lead Sponsor:
Clinuvel (UK) Ltd.
Treatments:
Afamelanotide